Last news
China's enduring commitment to peaceful development: a consistent path across past, present, and future

China's enduring commitment to peaceful development: a consistent path across past, present, and future

BEIJING, Oct. 20, 2025 /PRNewswire/ -- A report from People's Daily: Amid a turbulent and rapidly evolving global landscape, one principle remains consistent in China's international engagement: its unwavering commitment to peaceful development....

CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025

CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025

SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational clinical trial...

Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity

Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity

- The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) of s mall m olecule GLP-1 receptor ( GLP-1R) a gonist ASC30 in 65 participants...

ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)

ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)

SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key...

Leading Competition Economist Dr. Luke Wainscoat Joins The Brattle Group

Leading Competition Economist Dr. Luke Wainscoat Joins The Brattle Group

SYDNEY, Oct. 20, 2025 /PRNewswire/ -- The Brattle Group has welcomed Dr. Luke Wainscoat to its growing Sydney office as a Principal in the firm's Antitrust & Competition practice. An economist with 20 years of experience, Dr. Wainscoat advises...

Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances

Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances

SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the...

Webull Reduces Minimum ASX Trading Fee To $1

Webull Reduces Minimum ASX Trading Fee To $1

Webull Australia now offers the lowest-cost CHESS-sponsored brokerage fee minimums for trading ASX shares The new pricing structure is paired with Webull's industry-leading technology and free live pricing data $1.00 minimum fees will be made...

Yaber Expands Its Global Footprint -- Now Available at JB Hi-Fi Across Australia

Yaber Expands Its Global Footprint -- Now Available at JB Hi-Fi Across Australia

SYDNEY, Oct. 20, 2025 /PRNewswire/ -- Yaber, a pioneer of entertainment projectors, now announces its official entry into JB Hi-Fi, one of Australia's largest home entertainment retailers. This marks another milestone in Yaber's global expansion,...

menu
menu